Table 1 Demographic variables of the patients
From: Transhiatal versus transthoracic esophagectomy for esophageal SCC: outcomes and complications
Group | TTE | THE | Total | p value |
|---|---|---|---|---|
Frequency of group | 144 (59.3%) | 99 (40.7%) | 243 | |
Sex | ||||
Female | 66 (45.8%) | 60 (60.6%) | 126 (51.9%) | 0.027 |
Male | 78 (54.2%) | 39 (39.4%) | 117 (48.1%) | |
Age | ||||
18–50 | 21 (14.7%) | 20 (20.2%) | 41 (16.9%) | 0.297 |
50–85 | 122 (85.3%) | 79 (79.8%) | 201 (83.1%) | |
Comorbidity | ||||
HTN | 2 (2.2%) | 0 (0.0%) | 2 (2.0%) | 1.000 |
HLP | 1 (1.1%) | 0 (0.0%) | 1 (1.0%) | |
Others | 17 (19.1%) | 2 (18.2%) | 19 (19.0%) | |
> 1 | 7 (7.9%) | 1 (9.1%) | 8 (8.0%) | |
Pathologic Stage of disease | ||||
I&II | 6 (9.1%) | 15 (16.9%) | 21 (13.5%) | 0.235 |
III | 60 (90.9%) | 74 (83.1%) | 134 (86.5%) | |
EUS Stage of disease | ||||
I&II | 7 (18.4%) | 2 (40.0%) | 9 (20.9%) | 0.277 |
III | 31 (81.6%) | 3 (60.0%) | 34 (79.1%) | |
Location of tumor | ||||
Upper | 1 (1.4%) | 0 (0.0%) | 1 (0.6%) | < 0.001 |
Middle | 60 (81.1%) | 13 (14.9%) | 73 (45.3%) | |
Lower | 13 (17.6%) | 74 (85.1%) | 87 (54.0%) |